Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Impact · against what's priced in

Lyra Therapeutics, Atra, and LXEO face immediate negative pressure following a sharp decline in share prices. The broader market is reacting to extreme institutional instability following reports that the DOJ threatened the Federal Reserve Chair with criminal indictment.

LYRA−1.00: No priced-in read yet
In context: Shares of Lyra Therapeutics experienced a significant plunge during Monday trading.
Read from the article alone
Actual

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

oil
ATRA
LXEO
LYRA
asia markets
commodities
doj
equities
europe markets
fed
gold

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

What matters in this story

Sell-Off Widens As Oil Rallies Amid Middle East Conflict

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

What matters in this story

Sell-Off Widens As Oil Rallies Amid Middle East Conflict

How each ticker is affected

Track these names every morning.

Persistent Oil Prices Threaten Inflation Outlook

Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita

Gold's $4,000 support breaks, but is the selloff overdone?

Dow Heads for 3rd Weekly Win Despite Tech Turmoil

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

What matters in this story

Next reads from the same story arc

Sell-Off Widens As Oil Rallies Amid Middle East Conflict

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

What matters in this story

Next reads from the same story arc

Sell-Off Widens As Oil Rallies Amid Middle East Conflict

How each ticker is affected

Track these names every morning.

Persistent Oil Prices Threaten Inflation Outlook

Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita

Gold's $4,000 support breaks, but is the selloff overdone?

Dow Heads for 3rd Weekly Win Despite Tech Turmoil